Government Affairs
Refine Search
Pharmaceutical
Key policy improvements needed as Australia's new Parliament gets back to business, says trade group
Medicines Australia chief executive Brendan Shaw has welcomed the formation of a new federal government and said Australia's pharmaceutical industry looks forward to working constructively with all political parties in the new Parliament. 13 September 2010
Pharmaceutical
The recent political unrest in Thailand will not have an immediate impact on pharmaceutical sales or the revenue earning opportunities of drugmakers because the demand for health care is relatively independent of the trends in the economy people get ill and need medicines despite drops in national wealth, according to Business Monitor International's fourth-quarter 2010 report on the country. However, 'note the word relatively,' it pointed out. 8 September 2010
Generics
The value of Argentina's pharmaceutical market is calculated to have reached 12.64 billion Argentinean pesos ($3.37 billion) in 2009, according to a new report from Business Monitor International. Through to 2014, BMI forecasts a compound annual growth rate (CAGR) of 14.36% and 9.78% in local currency and US dollar terms, with the market value topping 24.72 billion pesos ($5.37 billion). 3 September 2010
Biotechnology
The USA's Department of Justice has appealed a district judge's ruling to ban federal funding of embryonic stem cell in the US District Court in Washington DC, declaring that it wanted Judge Royce Lamberth to lift the injunction he imposed last week (The Pharma Letters August 26 and 31). 2 September 2010
Pharmaceutical
The US Food and Drug Administration this week launched an innovative performance management system designed to advance the President's commitment to transparency, public participation and collaboration in the work of government. 2 September 2010
Pharmaceutical
The Department of Revenue, under India's Union Ministry of Finance, has revised and introduced a new fee structure for processing applications for manufacturing licence and import and export certificated for narcotic drugs and psychotropic substances through an amendment to the Narcotic Drugs & Psychotropic Substances (NDPS) Rules, 1985, reports the local PharmaBiz news service. 2 September 2010
Pharmaceutical
Based on the findings of research conducted by Health Action International (HAI) Europe on the levels of financial disclosure and transparency among patient and consumer organizations at the European Medicines Agency (EMEA), HAI Europe concludes that the "EMEA appears to have failed in the monitoring and enforcement of its guidelines on financial transparency." 1 September 2010
Pharmaceutical
US Senator Chuck Grassley (Republican, Iowa), ranking member of the Committee on Finance, has now received a response to his July 29 letter to the new Centers for Medicare and Medicaid Services (CMS) Administrator, Donald Berwick, requesting information about funding of his former organization, the Institute for Healthcare Improvement. Dr Berwick declined to release key funding information, said Sen Grassley, who made the following comment. 1 September 2010
Biotechnology
Against a backdrop of some of the world's most sophisticated biological research labs, US Representative Steve Israel (Democrat, Huntington) last week issued a challenge to his colleagues in Congress: immediately upon their return from summer recess, he urged, they should pass legislation that would reverse a recent federal court decision that has brought embryonic stem cell research in the USA to a screeching halt (The Pharma Letter August 26). 31 August 2010
Pharmaceutical
Ruing the fact that so far no big concrete proposals for the Indian pharmaceutical industry have been issued by the government putting forward laws and regulations to guide drugmakers and medical researchers alike, VM Katoch, Director General of the Indian Council of Medical Research (ICMR) and Secretary, Health Services, Government of India said he was dismayed at the fact that India had 'great dreams but no pathway for reality.' 31 August 2010
Pharmaceutical
The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that was be presented at the 105th Annual Meeting of the American Sociological Association, in Atlanta earlier this month. 27 August 2010
Biotechnology
US Department of Health and Human Services Secretary Kathleen Sebelius on Friday released an examination of the federal government's system to produce medicines, vaccines, equipment and supplies needed for a health emergency, known as medical countermeasures. The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs reviews the process and makes recommendations for a better approach. 23 August 2010
article
Just ahead of the tightly fought and as of going to press still undecided Australian election which took place on August 21, an agreement was announced between the pharmaceutical trade group Medicines Australia and the Commonwealth Government that will reduce the price of hundreds of medicines on the Pharmaceutical Benefits Scheme (PBS), Medicines Australia told a Senate inquiry. 23 August 2010
Pharmaceutical
In his fiscal year 2011 budget amendments for the US Department of Health and Human Services presented for Congress consideration last Friday, President Barack Obama proposed increases for, among other things, HIV/AIDS treatment and prevention funding - possibly in response to this month's campaign by the AIDS Healthcare Foundation (AHF) advertising campaign denouncing the President for not keeping pre-election promises on funding for the condition (The Pharma Letter August 11). 23 August 2010
Generics
India's Ministry of Health and Family Welfare has acknowledged that spurious or fake drugs are sensitive issues affecting the health of the citizens as well as the prestige of the country's pharmaceutical trade interests, and there is a sense of urgency in tackling the menace. 18 August 2010
Generics
The US Congressional Budget Office has forecast nearly $2 billion in savings over 10 years if patent settlements, or pay-for-delay deals between originator drugmakers and generics companies were banned, and a Federal Trade Commission study that estimated savings of $3.5 billion annually. These findings are now questioned. 17 August 2010
Biotechnology
The development of biologic drugs has gradually become the key focus of all drug companies worldwide, large or small, major or start-up. Major pharmaceutical companies, which used to almost exclusively focus on small-molecule drugs, are now paying more attention to biologics. Growing numbers of small biopharma companies also focus on discovery and development of novel biologic drugs or niche technologies which are increasingly licensed in by major biopharma companies. 16 August 2010
Pharmaceutical
Paul Flynn (UK, SOC), former rapporteur of the Parliamentary Assembly of the Council of Europe (PACE) on the handling of the H1N1 pandemic, has welcomed this week's publication by the World Health Organization of the list of members of its Emergency Committee on the influenza pandemic, as well as their declarations of interest. 13 August 2010
Pharmaceutical
According to a report by the UK's Financial Times, the US Department of Justice is scrutinizing payments by leading pharmaceuticals companies for hospitality, consultants, licensing agreements and charitable donations in markets around the world as part of a wide-ranging corruption probe. 13 August 2010
Pharmaceutical
Agreeing to open up its drug safety files for the first time, the European Medicines Agency (EMEA) has said that it will release documents related to a drug used to treat severe forms of acne. This is with respect to a complainant, an Irish citizen, who had asked for the release of reports concerning suspected adverse reactions to the drug and, earlier this year, European Ombudsman P Nikiforos Diamandouros told the Agency to reconsider its policy (The Pharma Letter May 12). 12 August 2010
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze